CGRP receptor antagonists
US10166226B2 · kind B2 · utility
3Cited by
22References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2018 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Jan 29, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of formula wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.